STOCK TITAN

iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

iCAD, Inc. (NASDAQ: ICAD) announced it will release its third-quarter financial results for the period ending September 30, 2022, after market close on November 10, 2022. A conference call is scheduled for 4:30 PM ET on the same day, allowing investors and analysts to discuss the outcomes. The information aims to provide insights into the company's ongoing efforts in cancer detection and therapy solutions, reflecting its position as a leader in medical technology.

Loading...
Loading translation...

Positive

  • Scheduled release of financial results may indicate transparency and ongoing business operations.

Negative

  • None.
Argus Session date unavailable
+2.65% session move Open Argus
Details

News Market Reaction – ICAD

The recorded move for ICAD in the trading session of this news was +2.65%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on November 10, 2022.

Conference Call
Thursday, November 10, 2022 at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 393244
Webcast: https://www.webcaster4.com/Webcast/Page/2879/46603
   

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will iCAD release its third quarter results?

iCAD will release its third quarter financial results on November 10, 2022.

What time is the iCAD conference call?

The conference call is scheduled for 4:30 PM ET on November 10, 2022.

How can I access the iCAD conference call?

The conference call can be accessed domestically at 888-506-0062 and internationally at 973-528-0011, using conference ID 393244.

Keep reading